
Why the U.S. Is Underestimating COVID Reinfection
Many U.S. states aren’t rigorously tracking or investigating suspected cases of reinfection
Many U.S. states aren’t rigorously tracking or investigating suspected cases of reinfection
Late-stage clinical trials of the first two coronavirus vaccine candidates in the U.S. plan to recruit 60,000 Americans
Racial minorities and those with underlying health conditions may be at a greater risk from coronavirus infection, but have historically been less likely to be included in clinical trials...
Purchase of full-service packages to eradicate the virus can come without cost transparency
Evacuations may prove particularly challenging for nursing homes and people who receive care at home
The greasy buildup poses unrecognized risk in long-term care settings
More than a dozen medical centers hope to study donated tumor tissue before it degrades
Proponents hope the assessment will help ID the earliest stages of dementia
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account